Mutual Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$432K Buy
5,658
+48
+0.9% +$3.46K 0.01% 948
2025
Q4
$358K Sell
5,610
-19
-0.3% -$1.17K 0.01% 1018
2025
Q3
$355K Sell
5,629
-1,951
-26% -$136K 0.01% 1001
2025
Q2
$594K Sell
7,580
-4,356
-36% -$342K 0.01% 700
2025
Q1
$905K Buy
11,936
+528
+5% +$49.9K 0.03% 480
2024
Q4
$1.05M Buy
11,408
+525
+5% +$53.8K 0.03% 468
2024
Q3
$1.16M Sell
10,883
-6
-0.1% -$600 0.03% 436
2024
Q2
$1.1M Buy
10,889
+186
+2% +$18.5K 0.03% 458
2024
Q1
$1.07M Sell
10,703
-59
-0.5% -$5.19K 0.03% 456
2023
Q4
$967K Buy
10,762
+230
+2% +$18.3K 0.03% 459
2023
Q3
$808K Buy
10,532
+99
+0.9% +$8.21K 0.03% 481
2023
Q2
$873K Buy
10,433
+193
+2% +$15.7K 0.03% 470
2023
Q1
$864K Sell
10,240
-409
-4% -$35.1K 0.04% 464
2022
Q4
$867K Sell
10,649
-202
-2% -$16.3K 0.04% 444
2022
Q3
$771K Buy
10,851
+528
+5% +$47.5K 0.04% 440
2022
Q2
$927K Sell
10,323
-132
-1% -$13.7K 0.06% 358
2022
Q1
$1.17M Buy
10,455
+122
+1% +$14.3K 0.07% 333
2021
Q4
$1.25M Sell
10,333
-51
-0.5% -$5.67K 0.07% 332
2021
Q3
$1.05M Buy
10,384
+8
+0.1% +$883 0.06% 344
2021
Q2
$1.21M Buy
10,376
+94
+0.9% +$11.3K 0.07% 318
2021
Q1
$1.13M Sell
10,282
-494
-5% -$53.6K 0.08% 301
2020
Q4
$1.08M Sell
10,776
-393
-4% -$36.4K 0.08% 286
2020
Q3
$873K Buy
11,169
+492
+5% +$37.1K 0.08% 281
2020
Q2
$744K Buy
10,677
+110
+1% +$6.93K 0.07% 285
2020
Q1
$492K Buy
10,567
+1,651
+19% +$106K 0.07% 293
2019
Q4
$707K Buy
8,916
+679
+8% +$52.2K 0.08% 278
2019
Q3
$608K Buy
8,237
+307
+4% +$22K 0.08% 272
2019
Q2
$617K Sell
7,930
-31
-0.4% -$2.35K 0.08% 286
2019
Q1
$604K Buy
7,961
+153
+2% +$12.2K 0.09% 245
2018
Q4
$571K Buy
7,808
+54
+0.7% +$4.3K 0.11% 218
2018
Q3
$742K Buy
7,754
+315
+4% +$31.2K 0.11% 222
2018
Q2
$744K Buy
7,439
+6
+0.1% +$633 0.17% 180
2018
Q1
$785K Buy
7,433
+3,240
+77% +$328K 0.2% 166
2017
Q4
$388K Buy
+4,193
New +$381K 0.15% 185

Other funds holding EMN

Mutual Advisors's EMN Position: Q1 2026 in Review

Mutual Advisors increased its Eastman Chemical (EMN) stake by 0.86% in Q1 2026, buying an estimated $3.46K and bringing the position to 5,658 shares worth $432K. The position accounts for 0.01% of the portfolio, ranked #948.

Mutual Advisors first reported a position in EMN in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.25M in Q4 2021. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

  • Mutual Advisors held 5,658 shares of Eastman Chemical worth $432K as of Q1 2026.
  • Mutual Advisors bought 48 Eastman Chemical shares in Q1 2026, an estimated $3.46K.
  • Eastman Chemical made up 0.01% of Mutual Advisors's portfolio in Q1 2026, its #948 holding.
  • Mutual Advisors first reported a position in Eastman Chemical in Q4 2017 and has held it in 34 quarters since.
  • Mutual Advisors's Eastman Chemical position peaked at $1.25M in Q4 2021.
  • 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.